share_log

RBC Capital Maintains Sector Perform on Sage Therapeutics, Raises Price Target to $26

Benzinga ·  Feb 15 10:53

RBC Capital analyst Brian Abrahams maintains Sage Therapeutics (NASDAQ:SAGE) with a Sector Perform and raises the price target from $21 to $26.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment